Breaking News

BioDuro Launches Peptide Business Unit

Strengthens its peptide technology platform to meet the rapidly growing global demand for peptide-based therapeutics.

Author Image

By: Charlie Sternberg

Associate Editor

BioDuro, a global Contract Research, Development, and Manufacturing Organization (CRDMO), has launched a new Business Unit (BU) dedicated to advancing peptide drug discovery and development for its global biopharma partners, underscoring the company’s commitment to strengthening its peptide technology platform to meet the rapidly growing global demand for peptide-based therapeutics, including GLP-1 treatments. The peptide BU, which is already fully operational, will be led by Fengping Xiao, P...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters